The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Sildenafil restores cognitive function without affecting β-amyloid burden in a mouse model of Alzheimer's disease: Reinstatement of cognitive function by sildenafil
Open accessAbstract
BACKGROUND AND PURPOSE: Inhibitors of phosphodiesterase 5 (PDE5) affect signalling pathways by elevating cGMP, which is a second messenger involved in processes of neuroplasticity. In the present study, the effects of the PDE5 inhibitor, sildenafil, on the pathological features of Alzheimer's disease and on memory-related behaviour were investigated. EXPERIMENTAL APPROACH: Sildenafil was administered to the Tg2576 transgenic mouse model of Alzheimer's disease and to age-matched negative littermates (controls). Memory function was analysed using the Morris water maze test and fear conditioning tasks. Biochemical analyses were performed in brain lysates from animals treated with saline or with sildenafil. KEY RESULTS: Treatment of aged Tg2576 animals with sildenafil completely reversed their cognitive impairment. Such changes were accompanied in the hippocampus by a reduction of tau hyperphosphorylation and a decrease in the activity of glycogen synthase kinase 3β (GSK3β) and of cyclin-dependent kinase 5 (CDK5) (p25/p35 ratio). Moreover, sildenafil also increased levels of brain-derived neurotrophic factor (BDNF) and the activity-regulated cytoskeletal-associated protein (Arc) in the hippocampus without any detectable modification of brain amyloid burden. CONCLUSIONS AND IMPLICATIONS: Sildenafil improved cognitive functions in Tg2576 mice and the effect was not related to changes in the amyloid burden. These data further strengthen the potential of sildenafil as a therapeutic agent for Alzheimer's disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dose translation from animal to human studies revisited.
Reagan‐Shaw, S., Nihal, M., & Ahmad, N. (2008) · The FASEB Journal · doi:10.1096/fj.07-9574lsf · Cited by 6,524
Alzheimer's Disease Is a Synaptic Failure
Selkoe, D. J. (2002) · Science · doi:10.1126/science.1074069 · Cited by 4,420
Ca2+ Influx Regulates BDNF Transcription by a CREB Family Transcription Factor-Dependent Mechanism
Tao, X., Finkbeiner, S., Arnold, D. B., Shaywitz, A. J., & Greenberg, M. E. (1998) · Neuron · doi:10.1016/s0896-6273(00)81010-7 · Cited by 1,561
Effects of cAMP simulate a late stage of LTP in hippocampal CA1 neurons
Frey, U., Huang, Y.-Y., & Kandel, E. R. (1993) · Science · doi:10.1126/science.8389057 · Cited by 1,218 · cited 2×
“Phosphodiesterases (PDEs) are enzymes that hydrolyse the cyclic nucleotides cAMP or cGMP, which act as second messengers in intracellular signalling and in processes of neuroplasticity, such as long-term potentiation (Frey et al., 1993; Son et al., 1998).”
BackgroundTangle and neuron numbers, but not amyloid load, predict cognitive status in Alzheimer’s disease
Giannakopoulos, P., Herrmann, F. R., Bussière, T., Bouras, C., Kövari, E., Perl, D. P., Morrison, J. H., Gold, G., & Hof, P. R. (2003) · Neurology · doi:10.1212/01.wnl.0000063311.58879.01 · Cited by 1,118
Nagahara, A. H., Merrill, D. A., Coppola, G., Tsukada, S., Schroeder, B. E., Shaked, G. M., Wang, L., Blesch, A., Kim, A., Conner, J. M., et al. (2009) · Nature Medicine · doi:10.1038/nm.1912 · Cited by 1,034
Tau phosphorylation: the therapeutic challenge for neurodegenerative disease
Hanger, D. P., Anderton, B. H., & Noble, W. (2009) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2009.01.003 · Cited by 965
Synaptic Targeting by Alzheimer's-Related Amyloid β Oligomers
Lacor, P. N., Buniel, M. C., Chang, L., Fernandez, S. J., Gong, Y., Viola, K. L., Lambert, M. P., Velasco, P. T., Bigio, E. H., Finch, C. E., et al. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.3432-04.2004 · Cited by 954
Immunization reverses memory deficits without reducing brain Aβ burden in Alzheimer's disease model
Dodart, J.-C., Bales, K. R., Gannon, K. S., Greene, S. J., DeMattos, R. B., Mathis, C., DeLong, C. A., Wu, S., Wu, X., Holtzman, D. M., et al. (2002) · Nature Neuroscience · doi:10.1038/nn842 · Cited by 858
Research works printed but not linked: 60
- Ahlijanian, 2000, Hyperphosphorylated tau and neurofilament and cytoskeletal disruptions in mice overexpressing human p25, an activator of cdk5, Proc Natl Acad Sci USA, 97, 2910, 10.1073/pnas.040577797 · DOI · Paper page
- Alvarez, 2001, A Cdk5-p35 stable complex is involved in the beta-amyloid-induced deregulation of Cdk5 activity in hippocampal neurons, Exp Cell Res, 264, 266, 10.1006/excr.2001.5152 · DOI
- Avila, 2007, GSK-3 inhibitors for Alzheimer's disease, Expert Rev Neurother, 7, 1527, 10.1586/14737175.7.11.1527 · DOI
- Bernabeu, 1997, Involvement of hippocampal cAMP/cAMP-dependent protein kinase signaling pathways in a late memory consolidation phase of aversively motivated learning in rats, Proc Natl Acad Sci USA, 94, 7041, 10.1073/pnas.94.13.7041 · DOI · Paper page
- Dash, 1990, Injection of the cAMP-responsive element into the nucleus of Aplysia sensory neurons blocks long-term facilitation, Nature, 345, 718, 10.1038/345718a0 · DOI · Paper page
- Devan, 2004, Phosphodiesterase inhibition by sildenafil citrate attenuates the learning impairment induced by blockade of cholinergic muscarinic receptors in rats, Pharmacol Biochem Behav, 79, 691, 10.1016/j.pbb.2004.09.019 · DOI
- Devan, 2006, Phosphodiesterase inhibition by sildenafil citrate attenuates a maze learning impairment in rats induced by nitric oxide synthase inhibition, Psychopharmacology (Berl), 183, 439, 10.1007/s00213-005-0232-z · DOI
- Devan, 2007, Sildenafil citrate attenuates a complex maze impairment induced by intracerebroventricular infusion of the NOS inhibitor Nomega-nitro-L-arginine methyl ester, Eur J Pharmacol, 563, 134, 10.1016/j.ejphar.2007.02.008 · DOI
- Dickey, 2003, Selectively reduced expression of synaptic plasticity-related genes in amyloid precursor protein + presenilin-1 transgenic mice, J Neurosci, 23, 5219, 10.1523/JNEUROSCI.23-12-05219.2003 · DOI · Paper page
- Dickey, 2004, Amyloid suppresses induction of genes critical for memory consolidation in APP + PS1 transgenic mice, J Neurochem, 88, 434, 10.1111/j.1471-4159.2004.02185.x · DOI
- Elyaman, 2002, In vivo activation and nuclear translocation of phosphorylated glycogen synthase kinase-3beta in neuronal apoptosis: links to tau phosphorylation, Eur J Neurosci, 15, 651, 10.1046/j.1460-9568.2002.01899.x · DOI
- Guzowski, 2002, Insights into immediate-early gene function in hippocampal memory consolidation using antisense oligonucleotide and fluorescent imaging approaches, Hippocampus, 12, 86, 10.1002/hipo.10010 · DOI · Paper page
- Guzowski, 1997, Antisense oligodeoxynucleotide-mediated disruption of hippocampal cAMP response element binding protein levels impairs consolidation of memory for water maze training, Proc Natl Acad Sci USA, 94, 2693, 10.1073/pnas.94.6.2693 · DOI · Paper page
- Guzowski, 1999, Environment-specific expression of the immediate-early gene Arc in hippocampal neuronal ensembles, Nat Neurosci, 2, 1120, 10.1038/16046 · DOI · Paper page
- Haghikia, 2007, Long-term potentiation in the visual cortex requires both nitric oxide receptor guanylyl cyclases, J Neurosci, 27, 818, 10.1523/JNEUROSCI.4706-06.2007 · DOI
- Han, 2007, Neuronal competition and selection during memory formation, Science, 316, 457, 10.1126/science.1139438 · DOI · Paper page
- Hanger, 1992, Glycogen synthase kinase-3 induces Alzheimer's disease-like phosphorylation of tau: generation of paired helical filament epitopes and neuronal localisation of the kinase, Neurosci Lett, 147, 58, 10.1016/0304-3940(92)90774-2 · DOI · Paper page
- Hartell, 1996, Inhibition of cGMP breakdown promotes the induction of cerebellar long-term depression, J Neurosci, 16, 2881, 10.1523/JNEUROSCI.16-09-02881.1996 · DOI
- Hsiao, 1996, Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice, Science, 274, 99, 10.1126/science.274.5284.99 · DOI · Paper page
- Huang, 2006, Multiple roles for glycogen synthase kinase-3 as a drug target in Alzheimer's disease, Curr Drug Targets, 7, 1389, 10.2174/1389450110607011389 · DOI
- Impey, 1996, Induction of CRE-mediated gene expression by stimuli that generate long-lasting LTP in area CA1 of the hippocampus, Neuron, 16, 973, 10.1016/S0896-6273(00)80120-8 · DOI · Paper page
- Johnson-Wood, 1997, Amyloid precursor protein processing and A beta42 deposition in a transgenic mouse model of Alzheimer disease, Proc Natl Acad Sci USA, 94, 1550, 10.1073/pnas.94.4.1550 · DOI
- Josselyn, 2001, Long-term memory is facilitated by cAMP response element-binding protein overexpression in the amygdala, J Neurosci, 21, 2404, 10.1523/JNEUROSCI.21-07-02404.2001 · DOI · Paper page
- Koh, 2007, Inhibition of glycogen synthase kinase-3 suppresses the onset of symptoms and disease progression of G93A-SOD1 mouse model of ALS, Exp Neurol, 205, 336, 10.1016/j.expneurol.2007.03.004 · DOI
- Lau, 2002, Cdk5 as a drug target for the treatment of Alzheimer's disease, J Mol Neurosci, 19, 267, 10.1385/JMN:19:3:267 · DOI
- Lee, 2000, Neurotoxicity induces cleavage of p35 to p25 by calpain, Nature, 405, 360, 10.1038/35012636 · DOI · Paper page
- Lee, 2004, Progressive cognitive impairment and anxiety induction in the absence of plaque deposition in C57BL/6 inbred mice expressing transgenic amyloid precursor protein, J Neurosci Res, 76, 572, 10.1002/jnr.20127 · DOI
- Liu, 2002, Involvement of aberrant glycosylation in phosphorylation of tau by cdk5 and GSK-3beta, FEBS Lett, 530, 209, 10.1016/S0014-5793(02)03487-7 · DOI · Paper page
- Lopes, 2007, Amyloid-Beta and prion peptides: implications for Alzheimer's disease and prion-related encephalopathies, Cell Mol Neurobiol, 27, 943, 10.1007/s10571-007-9224-3 · DOI
- Loughney, 1998, Isolation and characterization of cDNAs encoding PDE5A, a human cGMP-binding, cGMP-specific 3′,5′-cyclic nucleotide phosphodiesterase, Gene, 216, 139, 10.1016/S0378-1119(98)00303-5 · DOI · Paper page
- Lu, 1999, Nitric oxide signaling contributes to late-phase LTP and CREB phosphorylation in the hippocampus, J Neurosci, 19, 10250, 10.1523/JNEUROSCI.19-23-10250.1999 · DOI · Paper page
- Lyford, 1995, Arc, a growth factor and activity-regulated gene, encodes a novel cytoskeleton-associated protein that is enriched in neuronal dendrites, Neuron, 14, 433, 10.1016/0896-6273(95)90299-6 · DOI · Paper page
- Malm, 2007, Pyrrolidine dithiocarbamate activates Akt and improves spatial learning in APP/PS1 mice without affecting beta-amyloid burden, J Neurosci, 27, 3712, 10.1523/JNEUROSCI.0059-07.2007 · DOI
- Mandelkow, 1992, Glycogen synthase kinase-3 and the Alzheimer-like state of microtubule-associated protein tau, FEBS Lett, 314, 315, 10.1016/0014-5793(92)81496-9 · DOI · Paper page
- Otth, 2002, AbetaPP induces cdk5-dependent tau hyperphosphorylation in transgenic mice Tg2576, J Alzheimers Dis, 4, 417, 10.3233/JAD-2002-4508 · DOI
- Patil, 2006, Modulatory effect of sildenafil in diabetes and electroconvulsive shock-induced cognitive dysfunction in rats, Pharmacol Rep, 58, 373
- Patrick, 1999, Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration, Nature, 402, 615, 10.1038/45159 · DOI · Paper page
- Paul, 2008, Signaling through cGMP-dependent protein kinase I in the amygdala is critical for auditory-cued fear memory and long-term potentiation, J Neurosci, 28, 14202, 10.1523/JNEUROSCI.2216-08.2008 · DOI
- Price, 1999, Tangles and plaques in nondemented aging and ‘preclinical’ Alzheimer's disease, Ann Neurol, 45, 358, 10.1002/1531-8249(199903)45:3<358::AID-ANA12>3.0.CO;2-X · doi:10.1002/1531-8249(199903)45:3<358::aid-ana12>3.0.co;2-x
- Prickaerts, 2002a, cGMP, but not cAMP, in rat hippocampus is involved in early stages of object memory consolidation, Eur J Pharmacol, 436, 83, 10.1016/S0014-2999(01)01614-4 · DOI
- Prickaerts, 2002b, Effects of two selective phosphodiesterase type 5 inhibitors, sildenafil and vardenafil, on object recognition memory and hippocampal cyclic GMP levels in the rat, Neuroscience, 113, 351, 10.1016/S0306-4522(02)00199-9 · DOI · Paper page
- Puerta, 2009, Phosphodiesterase 5 inhibitors prevent 3,4-methylenedioxymethamphetamine-induced 5-HT deficits in the rat, J Neurochem, 108, 755, 10.1111/j.1471-4159.2008.05825.x · DOI
- Puerta, 2010, Sildenafil protects against 3-nitropropionic acid neurotoxicity through the modulation of calpain, CREB, and BDNF, Neurobiol Dis, 38, 237, 10.1016/j.nbd.2010.01.013 · DOI
- Puzzo, 2009, Phosphodiesterase 5 inhibition improves synaptic function, memory, and amyloid-beta load in an Alzheimer's disease mouse model, J Neurosci, 29, 8075, 10.1523/JNEUROSCI.0864-09.2009 · DOI · Paper page
- Reed, 2010, Effect size of reference memory deficits in the Morris water maze in Tg2576 mice, Behav Brain Res, 212, 115, 10.1016/j.bbr.2010.03.037 · DOI
- Reyes-Irisarri, 2005, Neuronal expression of cAMP-specific phosphodiesterase 7B mRNA in the rat brain, Neuroscience, 132, 1173, 10.1016/j.neuroscience.2005.01.050 · DOI
- Ricobaraza, 2009, Phenylbutyrate ameliorates cognitive deficit and reduces tau pathology in an Alzheimer's disease mouse model, Neuropsychopharmacology, 34, 1721, 10.1038/npp.2008.229 · DOI · Paper page
- Rutten, 2005, The selective PDE5 inhibitor, sildenafil, improves object memory in Swiss mice and increases cGMP levels in hippocampal slices, Behav Brain Res, 164, 11, 10.1016/j.bbr.2005.04.021 · DOI
- Rutten, 2008, Selective PDE inhibitors rolipram and sildenafil improve object retrieval performance in adult cynomolgus macaques, Psychopharmacology, 196, 643, 10.1007/s00213-007-0999-1 · DOI
- Sasaki, 2002, Amyloid cored plaques in Tg2576 transgenic mice are characterized by giant plaques, slightly activated microglia, and the lack of paired helical filament-typed, dystrophic neurites, Virchows Arch, 441, 358, 10.1007/s00428-002-0643-8 · DOI
- Son, 1998, The specific role of cGMP in hippocampal LTP, Learn Mem, 5, 231, 10.1101/lm.5.3.231 · DOI
- Stanciu, 2001, Phosphorylated cAMP response element binding protein in the mouse brain after fear conditioning: relationship to Fos production, Brain Res Mol Brain Res, 94, 15, 10.1016/S0169-328X(01)00174-7 · DOI · Paper page
- Steward, 2001, Selective targeting of newly synthesized Arc mRNA to active synapses requires NMDA receptor activation, Neuron, 30, 227, 10.1016/S0896-6273(01)00275-6 · DOI · Paper page
- Thind, 2007, Pathological correlates of cognitive decline in Alzheimer's disease, Panminerva Med, 49, 191
- Tomidokoro, 2001, Abeta amyloidosis induces the initial stage of tau accumulation in APP(Sw) mice, Neurosci Lett, 299, 169, 10.1016/S0304-3940(00)01767-5 · DOI
- Tsai, 2004, Cdk5, a therapeutic target for Alzheimer disease?, Biochim Biophys Acta, 1697, 137, 10.1016/j.bbapap.2003.11.019 · DOI
- Tully, 2003, Targeting the CREB pathway for memory enhancers, Nat Rev Drug Discov, 2, 267, 10.1038/nrd1061 · DOI · Paper page
- Twomey, 2006, Presenilin-1 is an unprimed glycogen synthase kinase-3beta substrate, FEBS Lett, 580, 4015, 10.1016/j.febslet.2006.06.035 · DOI
- Vitolo, 2002, Amyloid beta -peptide inhibition of the PKA/CREB pathway and long-term potentiation: reversibility by drugs that enhance cAMP signaling, Proc Natl Acad Sci USA, 99, 13217, 10.1073/pnas.172504199 · DOI · Paper page
- Westerman, 2002, The relationship between Aβeta and memory in the Tg2576 mouse model of Alzheimer's disease, J Neurosci, 1, 1858, 10.1523/JNEUROSCI.22-05-01858.2002 · DOI · Paper page
Cited by
Phosphodiesterases as Therapeutic Targets for Alzheimer's Disease
García-Osta, A., Cuadrado-Tejedor, M., García-Barroso, C., Oyarzábal, J., & Franco, R. (2012) · ACS Chemical Neuroscience · doi:10.1021/cn3000907 · Cited by 259
Self-citationFang, J., Zhang, P., Zhou, Y., Chiang, C.-W., Tan, J., Hou, Y., Stauffer, S., Li, L., Pieper, A. A., Cummings, J., et al. (2021) · Nature Aging · doi:10.1038/s43587-021-00138-z · Cited by 206
Genetic reduction of Nrf2 exacerbates cognitive deficits in a mouse model of Alzheimer’s disease
Branca, C., Ferreira, E., Nguyen, T.-V., Doyle, K., Caccamo, A., & Oddo, S. (2017) · Human Molecular Genetics · doi:10.1093/hmg/ddx361 · Cited by 139
Orchestrated experience-driven Arc responses are disrupted in a mouse model of Alzheimer's disease
Rudinskiy, N., Hawkes, J. M., Betensky, R. A., Eguchi, M., Yamaguchi, S., Spires-Jones, T. L., & Hyman, B. T. (2012) · Nature Neuroscience · doi:10.1038/nn.3199 · Cited by 103
Cuadrado-Tejedor, M., Garcia-Barroso, C., Sanzhez-Arias, J., Mederos, S., Rabal, O., Ugarte, A., Franco, R., Pascual-Lucas, M., Segura, V., Perea, G., et al. (2015) · Clinical Epigenetics · doi:10.1186/s13148-015-0142-9 · Cited by 69
Self-citation
Metadata
- Authors
- Cuadrado-Tejedor, M., Hervias, I., Ricobaraza, A., Puerta, E., Pérez-Roldán, J., García-Barroso, C., Franco, R., Aguirre, N., & García-Osta, A.
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 2011-11-21
- Volume
- 164
- Issue
- 8
- Pages
- 2029-2041
- ISSN
- 0007-1188 (ISSN-L)
- OpenAlex
- W2124627119
- Cited by
- 209
- References
- 17
- FWCI
- 8.28
- Type
- journal article
- Language
- en
- Open access
- bronze
- Licence
- doi.wiley.com/10.1002/tdm_license_1.1 (tdm, 1380 d)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Sildenafil restores cognitive function without affecting β-amyloid burden in a mouse model of Alzheimer's disease: Reinstatement of cognitive function by sildenafil. https://app.cochat.ai/papers/10.1111/j.1476-5381.2011.01517.x
- The paper
- Cuadrado-Tejedor, M., Hervias, I., Ricobaraza, A., Puerta, E., Pérez-Roldán, J., García-Barroso, C., Franco, R., Aguirre, N., & García-Osta, A. (2011). Sildenafil restores cognitive function without affecting β-amyloid burden in a mouse model of Alzheimer's disease: Reinstatement of cognitive function by sildenafil. British Journal of Pharmacology. https://doi.org/10.1111/j.1476-5381.2011.01517.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.